Impact of CMV-specific immune reconstitution at the end of Letermovir prophylaxis on the development of late cytomegalovirus infection in patients with hematopoietic progenitor cell transplantation (INMUNOEND Study).

OBSERVATIONAL STUDY WITH MEDICINES